| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2009 (ast)
- наукова стаття, опублікована в лютому 2009 (uk)
- مقالة علمية نشرت في فبراير 2009 (ar)
- scientific article published on February 2009 (en)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| - Calcium channel blocker-related periperal edema: can it be resolved?
- Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine
- Selected major risk factors and global and regional burden of disease
- Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States.
- 2007 Guidelines for the Management of Arterial Hypertension
- Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker
- Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hy
- The role of existing and newer calcium channel blockers in the treatment of hypertension
- Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data
- Vasodilatory edema: a common side effect of antihypertensive therapy
- Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study
- Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance
- Pharmacotherapy review: calcium channel blockers
- Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension
- High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension
- Rationale for combination therapy as initial treatment for hypertension
- Control of Blood Pressure in the Community: An Unsolved Problem
- Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter?
|
| author name string
| |
| author name string
| - A Salvetti
- J Schrader
- P Brunel
- C Calvo
- E Akpinar
- M Weisskopf
- L Keeling
|
| rdfs:label
| - The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. (nl)
- The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (en)
- The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (ast)
|
| skos:prefLabel
| - The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. (nl)
- The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (en)
- The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (ast)
|
| name
| - The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. (nl)
- The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (en)
- The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (ast)
|
| title
| |
| title
| - The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1111/J.1742-1241.2008.01977.X
|
| ResearchGate publication ID
| |
| ResearchGate publication ID
| |
| PMCID
| |
| PMCID
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)